Business Lunch with Kerstin Sinkevicius (USA)
06-17, pr
|Vilnius
Off-the-record event for professional women, startup founders, C-Level executives, VC's & startup ecosystem leaders with a guest speaker to learn experiences, and challenges and share winning tips on building a multi-million company in life sciences. Event language English.
Laikas ir vieta
2024-06-17 12:00 – 14:00
Vilnius, Bernardinu str 8, 01124 Vilnius, Lithuania
Svečiai
Apie renginį
Join us for an invite-only business lunch with Kerstin Sinkevicius (USA), Vice-President and Head of Pharmacology at BridgeBio Oncology Therapeutics (BBOT), which has just completed an oversubscribed $200M private funding round, led by Cormorant Asset Management and co-led by Omega Funds with participation from affiliates of Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management, Enavate Sciences, Surveyor Capital (a Citadel company), Aisling Capital, Casdin Capital, and Longwood Fund.
Kerstin is leading the pharmacology team responsible for development candidate selection and IND-enabling studies to support the advancement of next-generation KRAS-G12C ON inhibitor, first-in-class PI3Kα:RAS breaker, and panKRAS inhibitor programs. She will share her professional journey and lessons learned with tips for fellow women entrepreneurs, executives, and investors. Learn more: https://www.linkedin.com/in/kerstin-sinkevicius/
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies, to improve outcomes for patients with cancers driven…